Home

Recent News

Dr. Fingert recently became a member of the American Ophthalmological Society (AOS), a professional association that is committed to "the advancement of ophthalmic science and art.” Read Dr. Fingert’s AOS thesis here.

Our genetic analysis of the Ocular Hypertension Treatment Study (OHTS) investigated the effect of genetic risk factors on the probability of participants with high intraocular pressure going on to develop glaucoma. We found that OHTS participants that carry a genetic risk factor in the TMCO1 gene have a significantly higher probability of developing glaucoma. Read more about this study here.